EcoDrugPlus

Ensembl ID : ENSDLAG00005027177
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSDLAG00005027203
Gene Symbol: -
Cross references: -
182 Possible Orthologues:

Ensembl ID : ENSDLAG00005028268
Gene Symbol: -
Cross references: -
351 Possible Orthologues:

Ensembl ID : ENSDLAG00005027121
Gene Symbol: -
Cross references: -
192 Possible Orthologues:

Ensembl ID : ENSDLAG00005028243
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSDLAG00005028281
Gene Symbol: -
Cross references: -
212 Possible Orthologues:

Ensembl ID : ENSDLAG00005028282
Gene Symbol: -
Cross references: -
210 Possible Orthologues:

Ensembl ID : ENSDLAG00005028405
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSDLAG00005028502
Gene Symbol: -
Cross references: -
494 Possible Orthologues:

Ensembl ID : ENSDLAG00005028564
Gene Symbol: -
Cross references: -
189 Possible Orthologues:

Ensembl ID : ENSDLAG00005028509
Gene Symbol: -
Cross references: -
190 Possible Orthologues:

Ensembl ID : ENSDLAG00005028784
Gene Symbol: -
Cross references: -
191 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).